Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000083

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 24, 2018
Accepted (ET)
Dec 31, 2018 · 2:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 24, 2018P1,000$0.0206A26,590,097D
Common StockDec 24, 2018P2,000$0.0206A26,592,097D
Common StockDec 24, 2018P1,000$0.0206A26,593,097D
Common StockDec 24, 2018P2,000$0.0206A26,595,097D
Common StockDec 24, 2018P100$0.0207A26,595,197D
Common StockDec 24, 2018P2,000$0.0207A26,597,197D
Common StockDec 24, 2018P2,000$0.0204A26,599,197D
Common StockDec 24, 2018P100$0.0204A26,599,297D
Common StockDec 24, 2018P1,000$0.0202A26,600,297D
Common StockDec 24, 2018P2,000$0.0202A26,602,297D
Common StockDec 24, 2018P1,000$0.0207A26,603,297D
Common StockDec 26, 2018P1,000$0.0203A26,604,297D
Common StockDec 26, 2018P1,000$0.0209A26,605,297D
Common StockDec 26, 2018P1,000$0.0198A26,606,297D
Common StockDec 26, 2018P1,000$0.0179A26,607,297D
Common StockDec 26, 2018P100$0.018A26,607,397D
Common StockDec 26, 2018P1,000$0.0179A26,608,397D
Common StockDec 26, 2018P2,000$0.0179A26,610,397D
Common StockDec 26, 2018P200$0.0179A26,610,597D
Common StockDec 26, 2018P3,000$0.0179A26,613,597D
Common StockDec 26, 2018P1,000$0.0192A26,614,597D
Common StockDec 26, 2018P1,000$0.0191A26,615,597D
Common StockDec 26, 2018P1,000$0.0194A26,616,597D
Common StockDec 26, 2018P1,000$0.0219A26,617,597D
Common StockDec 26, 2018P1,000$0.0208A26,618,597D
Common StockDec 26, 2018P1,000$0.0215A26,619,597D

Table II — derivative securities

No Table II lines on this filing.